Clinical Research Focus. 27th Edition Navigating the Challenges: The Impact of US-China Tensions on Biopharmaceutical Innovation       The escalating tensions between the US and China have permeated various sectors, including the biopharmaceutical industry, significantly impacting companies with footprints in both countries. This article explores the implications of these tensions, focusing on the case of WuXi AppTec and the Biotechnology Read more
Revolutionizing Diabetes Management: FDA Approves First Direct-to-Consumer Glucose Monitor The FDA has given the green light to the Dexcom Stelo Glucose Biosensor System, the first of its kind continuous glucose monitor (CGM) that will be available directly to consumers. Slated for release in summer 2024, this innovative device offers adults over 18 who do not rely on insulin a novel way to monitor their Read more
Navigating the Challenges: The Impact of US-China Tensions on Biopharmaceutical Innovation The escalating tensions between the US and China have permeated various sectors, including the biopharmaceutical industry, significantly impacting companies with footprints in both countries. This piece explores the implications of these tensions, focusing on the case of WuXi AppTec and the Biotechnology Innovation Organization’s (BIO) recent decision to sever ties. The BIO-WuXi Clash: What’s Going Read more
Exploring Clinical Trial Opportunities: Hungary’s 2024 Country Profile Hungary is recognized for its advanced regulatory framework and state-of-the-art healthcare infrastructure, attracting pharmaceutical companies and clinical research organizations (CROs) to carry out their clinical trials there. The country’s clinical trial approval process is efficient and streamlined, in line with European Union standards, which substantially shortens the time needed to initiate new trials. As a Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us